Omega Flex Q2 Earnings, Revenue Fall-November 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Omega Flex Q2 Earnings, Revenue Fall

Aug 12, 2026 2:07 PM

04:59 PM EDT, 08/12/2026 (MT Newswires) -- Omega Flex ( OFLX ) reported late Wednesday a Q2 earnings of $0.27 per diluted share, down from $0.41 a year earlier.

Revenue for the quarter ended June 30 was $24.1 million, down from $25.5 million a year ago.

Previous page： ADM CFO to resign as company faces US government investigation Next page： Copper output at Chile's Codelco set to rise this year, CESCO says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

ADM CFO to resign as company faces US government investigation

Apr 22, 2024

(Reuters) - Grain trader Archer-Daniels-Midland ( ADM ) said on Monday that Chief Financial Officer Vikram Luthar will resign from his role effective Sept. 30. Luthar is the highest-level executive to leave the firm since it disclosed accounting issues within its Nutrition division that later triggered two government investigations and forced it to revise six years of financial data. ADM...

Copper output at Chile's Codelco set to rise this year, CESCO says

Apr 22, 2024

SANTIAGO (Reuters) - Chile's state-run copper miner Codelco is poised to improve production this year and begin to climb from its lowest dip in a quarter century, the head of Chilean copper studies center CESCO said ahead of a major industry conference that starts Monday. Codelco is aiming to produce between 1.325 million and 1.390 million metric tons of copper...

Clearwater Analytics Completes Acquisition of Risk and Performance Analytics Solutions From Wilshire

Apr 22, 2024

06:00 PM EDT, 04/22/2024 (MT Newswires) -- Clearwater Analytics ( CWAN ) said Monday it completed the acquisition of risk and performance analytics products from Wilshire Advisors. Wilshire Axiom, Wilshire Atlas, Wilshire Abacus and Wilshire iQComposite will be integrated with Clearwater's offerings. Clearwater previously said the assets will cost $40 million and add about $7 million in annualized revenue. ...

U.S. FDA approves ImmunityBio's bladder cancer therapy

Apr 22, 2024

April 22 (Reuters) - The U.S. FDA approved ImmunityBio's ( IBRX ) combination therapy to treat a type of bladder cancer, the regulator said on Monday, which would help bring the company's first product to market. ...